nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association between Health-Related Quality of Life and Body Mass After Adjustable Gastric Banding: A Nonlinear Approach
|
Lin, Vincent W. |
|
2013 |
16 |
5 |
p. 823-829 7 p. |
artikel |
2 |
A Systematic Literature Review of Psychosocial and Behavioral Factors Associated with Initial Medication Adherence: A Report of the ISPOR Medication Adherence & Persistence Special Interest Group
|
Zeber, John E. |
|
2013 |
16 |
5 |
p. 891-900 10 p. |
artikel |
3 |
Compensation Mechanisms for Lost Productivity: A Comparison between Four European Countries
|
Knies, S. |
|
2013 |
16 |
5 |
p. 740-744 5 p. |
artikel |
4 |
Copyright/Subscription
|
|
|
2013 |
16 |
5 |
p. v- 1 p. |
artikel |
5 |
Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer
|
Paulden, Mike |
|
2013 |
16 |
5 |
p. 729-739 11 p. |
artikel |
6 |
Deciding Which Drugs Get Onto the Formulary: A Value-Based Approach
|
Seigfried, Raymond J. |
|
2013 |
16 |
5 |
p. 901-906 6 p. |
artikel |
7 |
Development and Initial Validation of the NCCN/FACT Symptom Index for Advanced Kidney Cancer
|
Rothrock, Nan E. |
|
2013 |
16 |
5 |
p. 789-796 8 p. |
artikel |
8 |
Does the Process of Deliberation Change Individuals’ Health State Valuations? An Exploratory Study Using the Person Trade-Off Technique
|
Robinson, Suzanne |
|
2013 |
16 |
5 |
p. 806-813 8 p. |
artikel |
9 |
Economic Analysis of the Intangible Impacts of Informal Care for People with Alzheimer’s Disease and Other Mental Disorders
|
Gervès, Chloé |
|
2013 |
16 |
5 |
p. 745-754 10 p. |
artikel |
10 |
Editorial Board
|
|
|
2013 |
16 |
5 |
p. IFC- 1 p. |
artikel |
11 |
Efficacy, Patient-Reported Outcomes (PROs), and Tolerability of the Changing Therapeutic Landscape in Patients with Metastatic Prostate Cancer (MPC): A Systematic Literature Review
|
Seal, Brian S. |
|
2013 |
16 |
5 |
p. 872-890 19 p. |
artikel |
12 |
Gastroprotective Strategies in Chronic NSAID Users: A Cost-Effectiveness Analysis Comparing Single-Tablet Formulations with Individual Components
|
de Groot, N.L. |
|
2013 |
16 |
5 |
p. 769-777 9 p. |
artikel |
13 |
Health Utility Assessment Using EQ-5D among Caregivers of Children with Autism
|
Khanna, Rahul |
|
2013 |
16 |
5 |
p. 778-788 11 p. |
artikel |
14 |
How Should We Deal with Patient Heterogeneity in Economic Evaluation: A Systematic Review of National Pharmacoeconomic Guidelines
|
Ramaekers, Bram L.T. |
|
2013 |
16 |
5 |
p. 855-862 8 p. |
artikel |
15 |
How Should We Value Future Health? Was NICE Right to Change?
|
Raftery, James |
|
2013 |
16 |
5 |
p. 699-700 2 p. |
artikel |
16 |
Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group
|
Gwadry-Sridhar, Femida H. |
|
2013 |
16 |
5 |
p. 863-871 9 p. |
artikel |
17 |
Instructions for Authors
|
|
|
2013 |
16 |
5 |
p. I-II nvt p. |
artikel |
18 |
Italian Population-Based Values of EQ-5D Health States
|
Scalone, Luciana |
|
2013 |
16 |
5 |
p. 814-822 9 p. |
artikel |
19 |
Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force
|
Garrison Jr., Louis P. |
|
2013 |
16 |
5 |
p. 703-719 17 p. |
artikel |
20 |
PHP97 Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement Decisions
|
Hogue, S |
|
2013 |
16 |
5 |
p. 906- 1 p. |
artikel |
21 |
Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey
|
Türel, Özden |
|
2013 |
16 |
5 |
p. 755-759 5 p. |
artikel |
22 |
Reviewing the Evidence to Inform the Population of Cost-Effectiveness Models within Health Technology Assessments
|
Kaltenthaler, Eva |
|
2013 |
16 |
5 |
p. 830-836 7 p. |
artikel |
23 |
Table of Contents
|
|
|
2013 |
16 |
5 |
p. i-iii nvt p. |
artikel |
24 |
Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival
|
Breunig, Ian M. |
|
2013 |
16 |
5 |
p. 760-768 9 p. |
artikel |
25 |
Updating the Canadian Hemophilia Outcomes–Kids Life Assessment Tool (CHO-KLAT Version2.0)
|
Young, Nancy L. |
|
2013 |
16 |
5 |
p. 837-841 5 p. |
artikel |
26 |
Validating and Improving the Reliability of the EORTC QLQ-C30 Using a Multidimensional Rasch Model
|
Shih, Ching-Lin |
|
2013 |
16 |
5 |
p. 848-854 7 p. |
artikel |
27 |
Value of Research and Value of Development in Early Assessments of New Medical Technologies
|
Retèl, Valesca P. |
|
2013 |
16 |
5 |
p. 720-728 9 p. |
artikel |
28 |
Where Are We on “Risk-Sharing” Agreements?
|
Neumann, Peter J. |
|
2013 |
16 |
5 |
p. 701-702 2 p. |
artikel |
29 |
Which Is More Valuable, Longer Survival or Better Quality of Life? Israeli Oncologists’ and Family Physicians’ Attitudes Toward the Relative Value of New Cancer and Congestive Heart Failure Interventions
|
Greenberg, Dan |
|
2013 |
16 |
5 |
p. 842-847 6 p. |
artikel |
30 |
Willingness to Pay for Diagnostic Technologies: A Review of the Contingent Valuation Literature
|
Lin, Pei-Jung |
|
2013 |
16 |
5 |
p. 797-805 9 p. |
artikel |